Mural Oncology (MURA) Competitors $2.09 0.00 (0.00%) Closing price 09/24/2025 04:00 PM EasternExtended Trading$2.09 0.00 (0.00%) As of 05:19 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MURA vs. BHST, CYBN, ELDN, ACOG, NKTX, CLYM, LFVN, CRDF, KALA, and AVTXShould you be buying Mural Oncology stock or one of its competitors? The main competitors of Mural Oncology include BioHarvest Sciences (BHST), Cybin (CYBN), Eledon Pharmaceuticals (ELDN), Alpha Cognition (ACOG), Nkarta (NKTX), Climb Bio (CLYM), Lifevantage (LFVN), Cardiff Oncology (CRDF), KALA BIO (KALA), and Avalo Therapeutics (AVTX). These companies are all part of the "pharmaceutical products" industry. Mural Oncology vs. Its Competitors BioHarvest Sciences Cybin Eledon Pharmaceuticals Alpha Cognition Nkarta Climb Bio Lifevantage Cardiff Oncology KALA BIO Avalo Therapeutics BioHarvest Sciences (NASDAQ:BHST) and Mural Oncology (NASDAQ:MURA) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, dividends, valuation, earnings, profitability and analyst recommendations. Do institutionals & insiders believe in BHST or MURA? 80.2% of Mural Oncology shares are held by institutional investors. 2.2% of Mural Oncology shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Do analysts rate BHST or MURA? BioHarvest Sciences currently has a consensus target price of $13.67, suggesting a potential upside of 15.82%. Mural Oncology has a consensus target price of $12.00, suggesting a potential upside of 474.16%. Given Mural Oncology's higher probable upside, analysts plainly believe Mural Oncology is more favorable than BioHarvest Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioHarvest Sciences 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Mural Oncology 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50 Which has better earnings and valuation, BHST or MURA? BioHarvest Sciences has higher revenue and earnings than Mural Oncology. BioHarvest Sciences is trading at a lower price-to-earnings ratio than Mural Oncology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioHarvest Sciences$25.19M7.69-$12.91M-$0.70-16.86Mural OncologyN/AN/A-$128.51M-$8.59-0.24 Is BHST or MURA more profitable? Mural Oncology has a net margin of 0.00% compared to BioHarvest Sciences' net margin of -39.95%. Mural Oncology's return on equity of -107.76% beat BioHarvest Sciences' return on equity.Company Net Margins Return on Equity Return on Assets BioHarvest Sciences-39.95% -11,357.84% -39.94% Mural Oncology N/A -107.76%-87.57% Does the media favor BHST or MURA? In the previous week, BioHarvest Sciences had 1 more articles in the media than Mural Oncology. MarketBeat recorded 3 mentions for BioHarvest Sciences and 2 mentions for Mural Oncology. BioHarvest Sciences' average media sentiment score of 0.57 beat Mural Oncology's score of 0.00 indicating that BioHarvest Sciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BioHarvest Sciences 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Mural Oncology 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more risk and volatility, BHST or MURA? BioHarvest Sciences has a beta of 0.68, suggesting that its share price is 32% less volatile than the S&P 500. Comparatively, Mural Oncology has a beta of 2.99, suggesting that its share price is 199% more volatile than the S&P 500. SummaryBioHarvest Sciences beats Mural Oncology on 8 of the 15 factors compared between the two stocks. Get Mural Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for MURA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MURA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MURA vs. The Competition Export to ExcelMetricMural OncologyMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$36.21M$2.56B$5.77B$10.41BDividend YieldN/A56.32%5.68%4.62%P/E Ratio-0.2423.6376.0426.42Price / SalesN/A580.52521.33168.33Price / CashN/A174.1537.5661.52Price / Book0.255.2912.876.39Net Income-$128.51M$32.95M$3.29B$271.13M7 Day Performance0.48%1.40%0.80%0.93%1 Month Performance1.46%6.35%4.91%7.52%1 Year Performance-34.69%2.70%67.75%30.06% Mural Oncology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MURAMural Oncology2.1672 of 5 stars$2.09flat$12.00+474.2%-34.7%$36.21MN/A-0.24119BHSTBioHarvest Sciences1.7606 of 5 stars$8.72-4.0%$13.67+56.7%N/A$143.18M$25.19M-12.46N/ACYBNCybin2.8152 of 5 stars$6.04+0.5%$85.00+1,307.3%N/A$142.48MN/A-1.3850ELDNEledon Pharmaceuticals2.993 of 5 stars$2.37-3.7%$10.00+321.9%-4.0%$141.92MN/A-2.0310News CoveragePositive NewsACOGAlpha Cognition2.0064 of 5 stars$8.72-7.7%$20.00+129.4%N/A$140.92MN/A-5.45N/APositive NewsGap UpNKTXNkarta2.2144 of 5 stars$1.95-1.0%$13.60+597.4%-56.6%$138.50MN/A-1.32140CLYMClimb Bio3.5097 of 5 stars$2.01-1.5%$9.00+347.8%N/A$136.21MN/A-2.879Positive NewsAnalyst ForecastLFVNLifevantage3.9595 of 5 stars$10.71+0.3%$30.50+184.8%-5.5%$135.91M$228.53M14.47260CRDFCardiff Oncology1.6939 of 5 stars$2.00-2.0%$10.63+431.3%-21.0%$133.05M$545K-2.3020Positive NewsKALAKALA BIO4.1918 of 5 stars$18.32-4.8%$21.75+18.7%+246.7%$128.61M$3.89M-2.7030AVTXAvalo Therapeutics3.966 of 5 stars$9.76-3.7%$30.00+207.4%+19.0%$128.34M$440K0.0040High Trading Volume Related Companies and Tools Related Companies BioHarvest Sciences Competitors Cybin Competitors Eledon Pharmaceuticals Competitors Alpha Cognition Competitors Nkarta Competitors Climb Bio Competitors Lifevantage Competitors Cardiff Oncology Competitors KALA BIO Competitors Avalo Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MURA) was last updated on 9/25/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mural Oncology PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Mural Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MURA Stock Alerts